Development and Implementation of COVID-19 Immune Assay(s) Development and Implementation
This contract has been archived. It is preserved as a historical record.
Similar active opportunities:
This opportunity has closed
Similar active opportunities you might be interested in:
- Broad Agency Announcement: Joint All-DomainTransformational Model Battle Management Decision Advantage Sprint for Human-machine teaming events (JADPACT DASH)Due: May 9, 2028
- SBIR Phase II TACFI -Super Jammer Vehicle Arm Integration-
- Assessment of Sensing-Autonomy Sensor Exploitation Technologies (ASSET)
Key Takeaways
- No response deadline specified - contact the agency for details
- Full and open competition - all businesses eligible to bid
- Work to be performed in Washington, DC
- Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Contract Details
- Notice ID
- BARDA-IEIDD-063025
- Opportunity Type
- Justification
- Sub-Agency
- OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
- Office
- ASPR BARDA DIV CONTRACTS MGMT & ACQ
- Posted Date
- Monday, June 30, 2025
- Response Deadline
- Not specified
- PSC Code
- AN12
- Set-Aside
- Full & Open Competition
- Place of Performance
- Washington, DC, 20515
- Status
- Active
Description
This procurement is aimed at providing a central laboratory capacity site for analysis of mucosal and serum samples collected from subjects enrolled in multiple USG-sponsored COVID-19 vaccine trials. This action covers efforts to utilize the validated virus neutralization (VN) and binding assays to support these studies. The program goals are: 1. Establish validated VN and binding assays for SARS-CoV-2 emerging variant(s). 2. Test serum samples from human subjects enrolled in clinical trials of COVID-19 vaccine candidates in variant VN and binding antibody assays in compliance with GCLP guidelines.
Why This Opportunity Matters
HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking responses for research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology) in Washington, DC.
Similar Opportunities
Browse Related
Looking for more opportunities?
Browse our full directory of government contracts
